ZLZhuyi Li

Zhuyi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhuyi Li has a total of 176 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Zhang

    Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an City, Shaanxi Province 710038, China; Institute of Functional Brain Disorders, Tangdu Hospital, Fourth Military Medical University, Xi'an City, Shaanxi Province 710038, China

    9 shared publications
  • Jianting Miao

    Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an City, Shaanxi Province 710038, China

    7 shared publications
  • Hongzeng Li

    Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, China

    6 shared publications
  • Rui Liu

    Department of Neurology, Tangdu Hospital, Air Force Medical University, Xi'an, China

    6 shared publications
  • Ying Du

    Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi’an City, China

    6 shared publications
  • Miao Bai

    Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an City, Shaanxi Province 710038, China

    5 shared publications

Latest Publications

  • Open Access

    Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients

    by Ye Lin, Ting Chang, Jiaji Lin, Chenjing Sun, Chao Wei, Jiao Zhao, Rui Liu, Kun Yang, Zhuyi Li

    Myasthenia gravis (MG) is an autoimmune disease mediated by B cells secreting autoantibodies. Regulatory B (Breg) cells confirmed to have an immunosuppressive function play an important role in many autoimmune diseases. However, what about the changes in Breg cells in the thymus and peripheral blood of MG patients? The changes in the proportion of Breg cells in the peripheral blood of 41 MG patients without any drug treatment and 30 healthy controls were detected by flow cytometry. We found that the proportions of CD19+IL-10+cells and CD19+CD24hiCD38hicell subsets in MG patients were significantly lower than those in healthy controls. Then, we detected the proportion of CD19+IL-10+cells in thymus tissues of 10 healthy children, 4 healthy adults, and 12 MG patients by flow cytometry. However, the percentage of CD19+IL-10+cells was highest in healthy children (~8%), followed by healthy adults (~3%), and was lowest in MG patients (~0.5%). CD19+CD24hiCD38hiB cells exerted immunosuppressive functions in healthy people but were refractory in MG patients. Moreover, p-STAT3 downstream of CD40 may be impaired in CD24hiCD38hiB cells from the peripheral blood of MG patients.


  • Open Access

    Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China

    by Jiaqi Ding, Sijia Zhao, Kaixi Ren, Dan Dang, Hongzeng Li, Fang Wu, Min Zhang, Zhuyi Li, Jun Guo

    Background: It is well demonstrated that immunosuppressants can reduce, but not eliminate the risk of generalized development in ocular myasthenia gravis (OMG). In this study, we aimed to explore the predictive factors of generalized conversion of OMG patients who received immunosuppressive treatments. Methods: OMG patients under immunosuppressive treatments in Tangdu Hospital from June 2008 to June 2012 were retrospectively reviewed. Baseline clinical characteristics were documented. Patients were followed up regularly by face-to-face interview and the main outcome measure was generalized conversion. The logistic regression analysis was performed to determine the predictive factors of generalization of OMG. Results: Two hundred twenty-three eligible OMG patients completed the final follow-up visit and 38 (17.0%) progressed to generalized MG (GMG) at a median time to generalization of 0.9 year. Patients with adult onset and positive repetitive nerve stimulation (RNS) of facial or axillary nerve had higher conversion rate than those with juvenile onset and negative RNS (p = 0.001; p = 0.019; p = 0.015, respectively). Adult-onset patients converted earlier than juvenile-onset OMG patients (p = 0.014). Upon multivariate logistic regression analysis, age of onset (Odds ratio [OR] 1.023, 95% confidence interval [CI] 1.006–1.041, p = 0.007) and positive facial nerve RNS (OR 2.826, 95%CI 1.045–5.460, p = 0.038) were found to be positively associated with generalized development. Moreover, an obviously negative association was found for disease duration (OR 0.603, 95%CI 0.365–0.850, p = 0.019). Conclusions: Age of onset, disease duration and facial nerve RNS test can predict generalized conversion of OMG under immunosuppressive therapy. Adult-onset, shorter disease duration and facial nerve RNS-positive OMG patients have a higher risk of generalized development.


  • Open Access

    Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma

    by Chao Sun, Liming Xiao, Yuanlin Zhao, Jiankuan Shi, Yuan Yuan, Yu Gu, Feng Zhang, Xing Gao, Ying Yang, Risheng Yang, et al.


  • Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours

    by Chao Sun, Yuanlin Zhao, Jiankuan Shi, Jin Zhang, Yuan Yuan, Yu Gu, Feng Zhang, Xing Gao, Chao Wang, Yingmei Wang, et al.

    Tumour-associated angiogenesis is associated with the malignancy and poor prognosis of glioma. Isocitrate dehydrogenase (IDH) mutations are present in the majority of lower-grade (WHO grade II and III) and secondary glioblastomas, but their roles in tumour angiogenesis remain unclear.


  • Open Access

    Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients

    by Sijia Zhao, Jiaqi Ding, Shengyuan Wang, Chuan Li, Peng Guo, Min Zhang, Zhuyi Li

    Myasthenia gravis (MG) is a rare prototypical autoimmune disorder caused by antibodies (Ab) against postsynaptic membrane proteins. Most reports have investigated the role of autoimmune regulator gene (Aire) in thymic tissue in machianism of MG initiation. So far, the expression of Aire in human peripheral blood cells (we call it circulating Aire expression in the following passage) has not been reported. Herein, we explore the expression of Aire in peripharal blood, circulating T-follicular helper (cTfh) and T-follicular regulatory (cTfr) cells in MG patients. In our research, we found that the acetylcholine receptor (AChR) Ab level is higher in generalized MG (GMG) than that in ocular MG (OMG). Compared with the control group (CG), lower expression of Aire was found in MG patients, especially in GMG. The ratio of Tfh/Tfr was higher in GMG patients, and then in the OMG patients, and lowest in CG. All these differences above were statistically significant. Negative relation was discovered between expression of Aire in circulating blood and ratio of Tfh/Tfr, so did it exist between Aire expression and the severity of MG. Meanwhile, positive relation was discovered between ratio of Tfh/Tfr and the severity of MG. However, no significant relation was manifested in our study between the subset age of MG and Aire level. Overall, these findings imply circulating Aire might play a role in the imbalance of cTfh and cTfr cells and participate in the pathogenesis of MG.


  • Clinical differences of early and late-onset myasthenia gravis in 985 patients

    by Lingling Fan, Shan Ma, Yongxiang Yang, Zhongjun Yan, Junchao Li, Zhuyi Li

    Objective: The clinical differences of early-onset myasthenia gravis (EOMG) and late-onset MG (LOMG) have not been elucidated in China. In order to clarify this, a retrospective study was conducted in 985 MG patients, whose disease duration was longer than 3 years. Methods: These patients were separated into EOMG and LOMG according to the onset age of 50 years. The clinical differences including demographics, clinical features, thymus abnormalities and comorbidities of EOMG and LOMG patients were analyzed. Results: Results indicated that 485 were males and 500 were females, 714 were EOMG and 271 were LOMG. Female was more common in EOMG and male was more common in LOMG (p = 0.003). The peak onset age was 0–4 years in EOMG and 55–59 years in LOMG. Ocular MG (OMG) was more common in EOMG and generalized MG (GMG) was more common in LOMG (p = 0.004). The transformation rate of OMG to GMG was higher in LOMG (p = 0.002). The positive incidence of repetitive nerve stimulation (RNS) was higher in EOMG (p = 0.026). Thymoma was more frequent in LOMG (p = 0.017) and thymic hyperplasia was more frequent in EOMG (p < 0.001). Hyperthyroidism was more common in EOMG (p = 0.017) and diabetes was more common in LOMG (p < 0.001). Conclusion: These results have potential significance for the recognition of clinical features and the determination of management strategies in EOMG and LOMG.


  • Joint Channel Estimation and Signal Detection for FBMC Based on Artificial Neural Network

    by Zhuyi Li, Ming Lei, Minjian Zhao, Min Lit

    Filter Bank MultiCarrier with Offset Quadrature Amplitude Modulation (FBMC-OQAM) has been intensively studied, and becomes a very potential candidate in future wireless communication system because of its numerous advantages. This paper presents a framework of Artifical Neural Network (ANN)-aided receiver design for the FBMC system. Specifically, two new joint channel estimation and equalization architectures are developed, which are based on two classical ANN algorithms, Multi-layer Perceptron (MLP) and Functinal Link Artificial Neural Network (FLANN). In addition, a powerful Loss Function (LF) is proposed by combining intrinsic characteristics of FBMC and is applied in the ANN-aided FBMC receiver. Numerical results validate the effectiveness of the proposed ANN-aided design and demonstrate its remarkable bit-error-ratio (BER) performance under multi-path channel environment. Furthermore, the performance advantage of the proposed LF is also confirmed by simulations.


    • 1 January 2018
      • Vol. 34  (1) , 28-34

    [Knockdown of dopamine receptor D2 upregulates the expression of adiogenic genes in mouse primary mesencephalic neurons].

    by Jiaqi Ding, Xiaoli Chen, Jiaji Lin, Junling Zhu, Zhuyi Li

    Objective To study the effects of dopamine receptor D2 (DRD2) on the adipogenesis genes in mouse primary mesencephalic neurons. Methods The lentiviral vectors which expressed specific shRNA targeting DRD2 were constructed to decrease DRD2 expression in mouse primary mesencephalic neurons. High throughput sequencing (HTS) analysis was used to investigate gene expression changes between the DRD2 knock-down group and the negative control group. Real-time quantitative PCR (qRT-PCR) and Western blot analysis were applied to verify the differently expressed genes. Fatty acids were measured by fatty acid detection kit. Results DRD2 expression was effectively down-regulated in mouse primary mesencephalic neurons by lentiviral vectors. HTS revealed adipogenesis genes were significantly up-regulated after DRD2 down-regulation, mainly including delta(14)-sterol reductase, acetyl-coenzyme A synthetase, insulin-induced gene 1 protein and especially stearoyl-coenzyme A desaturase 1 (SCD1, 4-fold upregulated). The qRT-PCR and Western blot analysis verified that SCD1 was upregulated 2.6 folds and 2 folds respectively by lentiviral DRD2-shRNA vectors. Moreover, the SCD1-related free fatty acids were significantly more increased than the negative control group. Conclusion DRD2 in primary mesencephalic neurons had a significant regulative effect on the adipogenesis genes. The up-regulation of SCD1 can accelerate the conversion of saturated fatty acids to monounsaturated fatty acids and prevent the damage of lipid toxicity to cells.

  • Open Access

    Irrelevance of anti-nAChR cytoplasmic loop antibody in the degree of myasthenia gravis

    by Ye Lin, Chen Song, Jiang Xu, Yongxiang Yang, Hang Qin, Cong Zhao, Jiaji Lin, Rui Liu, Zhuyi Li

    Anti‑nicotinic acetylcholine receptor (nAChR) antibody in myasthenia gravis (MG) usually refers to that against the extracellular domain (ECD) of nAChR. However, growing evidence has indicated that there also exists the nAChR antibody against the nAChR cytoplasmic loop (CL) in patients with MG. Some studies have demonstrated that the anti‑CL antibody may play a protective role in animal models of experimental autoimmune MG. However, to date, limited or no information is available as to whether anti‑CL antibody plays a beneficial role in patients with MG. In this, we examined the levels of anti‑CL and anti‑ECD antibodies in the sera of 76 patients with MG from the MG sample bank of our department, including 29 generalized MG (gMG) and 47 ocular MG (OMG) cases, as well as 40 healthy controls by radioimmunoassay. We also analyzed the correlation between anti‑CL antibody levels and the degree of severity in patients with MG. Our results revealed that among the 76 patients with MG, 61 serum samples (80.3%) were positive for anti‑ECD nAChR antibody, among which 38 (38/61, 62.3%) were positive for anti‑CL antibody. The levels of anti‑ECD antibodies in gMG were higher than those in OMG; however, the levels of anti‑CL antibodies in gMG were comparable with those in OMG. No clear correlation was observed between the anti‑ECD antibody levels and those of anti‑CL antibody. Taken together, our findings provide the first clinical evidence of the possibly different role of anti‑CL antibody in patients with MG compared to its role in animal models of MG. Anti‑CL antibody may not exert a beneficial effect in patients with MG, but may play an as yet udetermined role in the development of MG.